Amgen (AMGN) PT Raised to $260 at BMO Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $439.26 -1.79%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
BMO Capital analyst Evan David Seigerman raised the price target on Amgen (NASDAQ: AMGN) to $260.00 (from $253.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Amgen (AMGN) PT Raised to $480 at Oppenheimer
- CoreWeave (CRWV) PT Lowered to $105 at UBS
- Boyd Gaming (BYD) PT Lowered to $80 at StoneX
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
